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almitoylation is postulated to regulate Ras signal-
ing by modulating its intracellular trafﬁcking and
membrane microenvironment. The mechanisms by
which palmitoylation contributes to these events are
poorly understood. Here, we show that dynamic turn-
over of palmitate regulates the intracellular trafﬁcking of
HRas and NRas to and from the Golgi complex by shift-
ing the protein between vesicular and nonvesicular
modes of transport. A combination of time-lapse micros-
copy and photobleaching techniques reveal that in the
absence of palmitoylation, GFP-tagged HRas and NRas
P
 
undergo rapid exchange between the cytosol and ER/
Golgi membranes, and that wild-type GFP-HRas and
GFP-NRas are recycled to the Golgi complex by a non-
vesicular mechanism. Our ﬁndings support a model
where palmitoylation kinetically traps Ras on mem-
branes, enabling the protein to undergo vesicular trans-
port. We propose that a cycle of depalmitoylation and
repalmitoylation regulates the time course and sites of
Ras signaling by allowing the protein to be released
from the cell surface and rapidly redistributed to intra-
cellular membranes.
 
Introduction
 
The small GTPase Ras is a major regulator of cell growth,
death, and differentiation (Katz and McCormick, 1997; Olson
and Marais, 2000; Shields et al., 2000; Downward, 2003). Ras
is targeted to the inner leaflet of the plasma membrane by two
motifs contained in its COOH-terminal hypervariable domain.
The first, shared by all the ubiquitously expressed Ras isoforms
(H-, N-, and KRas), is a COOH-terminal CAAX motif that un-
dergoes posttranslational modification by sequential farnesyl-
ation, proteolysis, and carboxyl methylation (Clarke, 1992).
The second varies between Ras isoforms, consisting of a poly-
basic domain for KRas 4B and either one or two palmitoylation
sites for NRas, HRas, and KRas 4A (Hancock et al., 1989,
1990, 1991a,b). Palmitoylation involves the reversible post-
translational modification of cysteine residues by the addition
of a palmitate through a thioester linkage (Smotrys and Linder,
2004). Farnesylation is absolutely required for binding of Ras
to cell membranes and Ras signaling, while mutations of the
“second signal” (i.e., the polybasic domain or palmitoylation
sites) partially disrupt membrane binding and lead to aberrant
signaling (Willumsen et al., 1984; Hancock et al., 1990; Kato
et al., 1992; Chiu et al., 2002).
The hypervariable domain additionally functions to regu-
late the subcellular distribution, intracellular trafficking, and
membrane microenvironment of Ras. The CAAX motif targets
Ras to the cytosolic face of the ER and Golgi apparatus, and
exit of Ras from these compartments requires either palmitoy-
lation or the polybasic domain (Choy et al., 1999; Apolloni et
al., 2000). How trafficking of Ras to the cell surface is accom-
plished depends on the nature of the second signal. The palmi-
toylated Ras isoforms HRas and NRas are delivered from the
Golgi complex to the cell surface as part of the secretory path-
way, whereas KRas 4B reaches the plasma membrane by an
unknown mechanism that is independent of vesicular transport.
The COOH-terminal membrane targeting motifs of Ras appear
to contain the relevant signals for Ras trafficking, as these mo-
tifs traffic GFP to the plasma membrane in a similar manner as
the full-length protein (Choy et al., 1999; Apolloni et al.,
2000). In adipocytes and yeast, HRas can traffic to the plasma
membrane by a nonclassical secretory transport pathway as
well as the classic secretory pathway (Dong et al., 2003; Watson
et al., 2003). Palmitoylated forms of Ras are also often found
associated with the Golgi complex where they can signal,
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providing a mechanism for regulation of isoform-specific Ras
signaling via their distinct subcellular localizations (for re-
view see Bivona and Philips, 2003; Hancock, 2003). The hy-
pervariable domain further contributes to specificity of Ras
signaling through different isoforms by targeting the proteins
to spatially and compositionally distinct plasma membrane
microdomains (for review see Hancock, 2003; Parton and
Hancock, 2004).
How palmitoylation contributes to the isoform-specific
trafficking and signaling of Ras has not been fully established.
One proposed function of palmitoylation is to enhance Ras
binding to membranes (Silvius and l’Heureux, 1994; Shahinian
and Silvius, 1995; Silvius, 2002). Palmitoylation may also reg-
ulate the sorting of Ras into vesicles destined for the cell sur-
face or targeted for clathrin-independent endocytosis (Smotrys
and Linder, 2004). Both mechanisms could be potentially mod-
ulated in a dynamic manner, as the palmitates on NRas and
HRas undergo dynamic turnover within minutes to hours (Ma-
gee et al., 1987; Lu and Hofmann, 1995; Baker et al., 2000,
2003). How this turnover is regulated and its significance for
Ras biology is not yet known, as the enzymes involved in the
regulation of Ras palmitoylation and depalmitoylation have
only recently begun to be identified (Linder and Deschenes,
2003, 2004; Dietrich and Ungermann, 2004; Smotrys and
Linder, 2004).
In this study, we examined the role of palmitoylation in
the intracellular transport of HRas and NRas to and from the
Golgi complex. Using quantitative fluorescence microscopy
and photobleaching techniques, we show that GFP-tagged mu-
tants of HRas and NRas lacking functional palmitoylation sites
undergo rapidly reversible binding to the ER and Golgi com-
plex. We also provide evidence that wild-type NRas and HRas
undergo a cycle of depalmitoylation and repalmitoylation that
allows them to recycle to the Golgi complex. We propose that
the reversible palmitoylation of Ras allows the protein to shift
between vesicular and nonvesicular modes of transport, and
ultimately controls the location and time course of intracellular
Ras signaling.
 
Results
 
GFP-CAAX and GFP-Ras palmitoylation 
mutants traffic extremely rapidly to the 
Golgi complex
 
Two models could explain why NRas and HRas are retained in
the ER and Golgi complex in the absence of palmitoylation
(Choy et al., 1999; Apolloni et al., 2000). First, Ras could un-
dergo vesicular transport between the ER and Golgi complex,
but require palmitoylation to allow it to enter into Golgi-derived
vesicles destined for the cell surface (Choy et al., 1999). Second,
the membrane binding affinity of the protein could be reduced in
absence of palmitoylation, allowing it to undergo reversible
binding to ER and Golgi membranes (Hancock et al., 1989,
1991b; Shahinian and Silvius, 1995). To distinguish between
these possibilities, we used photobleaching techniques to study
the kinetics of transport of GFP-tagged NRas and HRas palmi-
toylation mutants to the Golgi complex in COS-7 cells. For
comparison, we also examined GFP-CVLS, a substrate for far-
nesylation, and GFP-CLLL, a substrate for geranylgeranylation
(Choy et al., 1999). After photobleaching the fluorescent pro-
teins localized to the Golgi complex, recovery of fluorescence
from outside the bleach region occurred extremely rapidly and
completely, with a half time of 
 
 
 
10 s and a mobile fraction
(Mf) of 
 
 
 
95% (Fig. 1). Recovery kinetics were identical for the
GFP-HRas and GFP-NRas palmitoylation mutants, whereas the
recovery of GFP-CLLL was twofold slower (Fig. 1 C). These
rapid rates of recovery are several orders of magnitude faster
than the kinetics of typical vesicular transport from the ER to
the Golgi for the transmembrane proteins VSVG-GFP and
GalTase-GFP (rate constants of 2.8%/min and 3.6%/min, re-
spectively) (Hirschberg et al., 1998; Zaal et al., 1999), but are
consistent with a rapidly reversible membrane binding event.
Figure 1. GFP-CAAX proteins and GFP-Ras palmi-
toylation mutants traffic rapidly between the ER and
Golgi complex. (A) The Golgi-associated pool of a
GFP-HRas C181S, C184S recovers rapidly and com-
pletely within 1 min after photobleaching of the entire
Golgi complex (circle, t   0). Bar, 10  m. (B) Kinet-
ics of fluorescence recovery after bleaching the entire
Golgi-associated pool of GFP-CVLS (circles), GFP-CLLL
(closed squares), GFP-HRas C181S, C184S (open
squares), and GFP-NRas C181S (triangles). Data are
from a representative experiment. For clarity, error
bars are not shown. (C) Halftimes of fluorescence re-
covery for Golgi photobleaching experiments. Data
are the mean   SE from four independent experi-
ments ( 10 cells per experiment). Golgi bleaches
were performed at 22 C. 
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Diffusional mobility measurements 
confirm that a fraction of CAAX-
containing proteins are present as a 
soluble pool
 
We next asked whether the ER-associated pools of protein like-
wise underwent reversible exchange with a soluble pool. To
test this, FRAP measurements were performed using a 4-
 
 
 
m-
wide strip centered on the ER while monitoring the fluores-
cence in the surrounding region of the cell (Fig. 2 A). Identical
recovery curves were obtained for the two Ras palmitoylation
mutants and GFP-CVLS, whereas the recovery of GFP-CLLL
was slightly slowed (Fig. 2 B). Mf for all proteins examined
was 
 
 
 
90%. The apparent diffusion coefficients (
 
D
 
) were 
 
 
 
5
 
 
 
m
 
2
 
/s for the palmitoylation mutants and GFP-CVLS (Fig. 2 C),
a value 10-fold faster than the diffusion coefficient for the
transmembrane protein VSVG-GFP in the ER (Nehls et al.,
2000). 
 
D
 
 for GFP-CLLL was significantly slower, 
 
 
 
2 
 
 
 
m
 
2
 
/s,
but was still twofold faster than the diffusional mobility of
GFP-HRas on the cell surface under identical conditions (Fig. 2,
B and C) (see also Niv et al., 2002; Kenworthy et al., 2004).
These recoveries are too fast to occur as the result of lateral dif-
fusion within the ER membrane, but could be explained if the
recovery was the result of a combination of membrane exchange
and lateral diffusion of both membrane-bound and cytosolic
pools of the protein (Rotblat et al., 2004).
To test this idea further we used a second technique to
measure protein diffusional mobility—fluorescence correlation
spectroscopy (FCS; for review see Dittrich et al., 2001). Im-
portantly, FCS can resolve two or more diffusing species, and
is also more sensitive to the diffusion of soluble proteins than
our confocal FRAP assay due to its higher temporal resolu-
tion. Although the autocorrelation curve for cytoplasmic GFP
was well described by a one-component fit with a characteris-
tic 
 
D
 
 of 
 
 
 
45 
 
 
 
m
 
2
 
/s, autocorrelation curves for the Ras palmi-
toylation mutants and GFP-CAAX proteins in the ER region
were shifted to a longer correlation time (
 
 
 
D
 
) (indicative of a
slower 
 
D
 
), and required a two-component fit to describe the
data (Fig. 3, A and B). 
 
D
 
 for the faster component (
 
D
 
1
 
) was
Figure 2. Diffusional mobilities of GFP-CAAX pro-
teins and GFP-Ras palmitoylation mutants in the ER
measured by confocal FRAP. (A) Representative im-
ages from a confocal FRAP measurement of the lateral
diffusion of GFP-NRasC181S in the ER. The bleach
box (white) is 4  m deep. Recovery occurs so rapidly
that it is difficult to see the bleached region at the 6.7-s
time point. Bar, 10  m. (B) Recovery curves from ER-
associated pools of GFP-CVLS (circles), GFP-CLLL
(squares), GFP-HRas C181S, C184S (diamonds), and
GFP-NRas C181S (crosses); t   22 C. Data are from
a representative experiment (n    10 cells/protein;
mean   SE). For comparison, a recovery curve for
GFP-HRas at the cell surface is shown (triangles). (C)
D for ER-associated protein calculated from confocal
FRAP experiments. D for GFP-HRas at the cell surface
is shown for comparison.
Figure 3. FCS detects both a soluble and
membrane-associated pool of GFP-CAAX
proteins and GFP-Ras palmitoylation mutants.
(A) Normalized FCS autocorrelation curves
for GFP-CVLS (circles), GFP-CLLL (squares),
GFP-HRas C181S, C184S (diamonds), and
GFP-NRasC181S (dotted line) measured in the
ER. As a control, measurements were also
made for cytosolic GFP (inverted triangle) un-
der similar conditions. Each curve is the aver-
age of 10 measurements on an individual cell
from a representative experiment. (B) A two-
component model (red) rather than a one-com-
ponent model (blue) is required to describe
the autocorrelation data for GFP-CVLS. The  D
for the fast component (174  s) is similar to
free GFP, whereas  D for the slower component
(3,195   s) corresponds to D of 2.3  m
2/s.
The inset shows a plot of the residuals for each
fit. FCS data were obtained at 22 C. 
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similar to that of GFP alone, whereas 
 
D
 
 for the slower com-
ponent (
 
D
 
2
 
) was identical within error (
 
 
 
2.6 
 
 
 
m
 
2
 
/s) for all
the proteins except GFP-CLLL (Table I). These findings sup-
port the notion that two pools of protein, one soluble and one
reversibly bound to membranes, exist under the conditions of
these experiments.
 
Two populations of GFP-HRas and 
GFP-NRas are localized to the Golgi 
complex under steady-state conditions
 
We next considered the role of palmitoylation in trafficking
wild-type HRas and NRas to the cell surface. Ras is found in
the Golgi complex, where it undergoes vesicular transport to
the cell surface in BHK and COS cells (Choy et al., 1999;
Apolloni et al., 2000). The presence of Ras on the Golgi com-
plex is in part due to the flux of newly synthesized protein
through the secretory pathway, as treatment of cells with cyclo-
heximide caused a partial loss of fluorescence from the Golgi
complex as assessed by fluorescence microscopy (Choy et al.,
1999). However, the Golgi-associated pool of Ras was not
completely chased out of the Golgi in pulse–chase experiments
(Choy et al., 1999), raising the possibility that one or more
pathways may recycle Ras to the Golgi complex in a post-
biosynthetic manner.
To test this hypothesis, we first confirmed that GFP-
NRas (Fig. 4 A) and GFP-HRas (unpublished data) remain
Golgi associated after cycloheximide treatment. We next asked
whether Golgi-associated Ras was actively trafficked to the
Golgi complex in the absence of new protein synthesis by pho-
tobleaching the entire Golgi-associated pool of protein, then
monitoring recovery of fluorescence in the area over time (Fig.
4 B). Both GFP-NRas and GFP-HRas recovered after pho-
tobleaching, with similar half times (48 
 
 
 
 9 s vs. 36 
 
 
 
 5 s,
respectively) but to differing extents (64 
 
 
 
 4% vs. 39 
 
 
 
 3%,
 
n
 
 
 
 
 
 33 and 23 cells, respectively). Thus, a fraction of both
wild-type GFP-HRas and GFP-NRas appear to be actively and
rapidly recycled to the Golgi complex; the remainder of the
protein, which does not recover after the bleach, appears to rep-
resent a stably bound pool.
 
The rapidly recovering population of 
Golgi-associated GFP-HRas and 
GFP-NRas is recycled to the Golgi 
complex by a nonvesicular mechanism
 
We hypothesized that the rapidly recovering pool of GFP-
HRas and GFP-NRas to the Golgi could be delivered there by
Figure 4. GFP-NRas and GFP-HRas are trafficked to
the Golgi complex in the absence of new protein syn-
thesis under steady-state conditions. (A) GFP-NRas is
localized to the Golgi complex in the absence of new
protein synthesis. Cells were either mock treated
(control) or incubated in the presence of 200  g/ml
cycloheximide (CHX) for 4 h at 37 C before imaging.
For comparison, the distribution of GFP-GPI, a protein
that cycles between the Golgi complex and cell sur-
face, is shown. Bar, 10  m. (B) The Golgi-associated
pool of GFP-NRas partially recovers after pho-
tobleaching of the entire Golgi compartment (white
circles, t   0). Cells were treated with cycloheximide
for 4 h before the experiment. Bar, 10  m. (C) Kinet-
ics of recovery of fluorescence in the Golgi complex
for GFP-HRas (closed squares) and GFP-NRas (open
circles) at 37 C (n   8–9 cells). Note the differences
in the extent of recovery for the two proteins. Data are
from a representative experiment. Similar results were
obtained in the presence or absence of cyclohexim-
ide. Bars   SE. (D) Kinetics of Golgi recovery for
GFP-NRas (open circles) versus GFP-GPI (closed
squares) at 37 C (n   6–9 cells). Bars   SE.
 
Table I. 
 
Diffusional mobility of GFP-CAAX proteins and GFP-Ras 
palmitoylation mutants in the ER measured by FCS
Protein
 
D
 
fast
 
% fast component
 
D
 
slow
 
 
 
m
 
2
 
/s %
 
 
 
m
 
2
 
/s
 
GFP-HRas mutant 43.6 
 
 
 
 3.4 (13) 79.9 
 
 
 
 3.0 2.78 
 
 
 
 0.44
GFP-NRas mutant 47.6 
 
 
 
 4.2 (16) 75.5 
 
 
 
 2.6 2.90 
 
 
 
 0.40
GFP-CVLS 41.9 
 
 
 
 4.2 (12) 79.4 
 
 
 
 3.0 2.49 
 
 
 
 0.72
GFP-CLLL 45.0 
 
 
 
 3.0 (11) 86.1 
 
 
 
 1.8 1.18 
 
 
 
 0.30
 
a
 
GFP 48.8 
 
 
 
 2.3 (9) 100 -
 
a
 
P 
 
 
 
 0.0001. 
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either endocytosis or nonvesicular transport. One candidate
endocytic mechanism is a clathrin-independent endocytic
pathway used for the internalization of lipid raft–associated
proteins and lipids such as GFP-GPI and cholera toxin B sub-
unit (CTXB) from the cell surface to the Golgi complex
(Nichols et al., 2001). We therefore compared the recovery of
GFP-NRas to GFP-GPI after bleaching of the Golgi region in
cycloheximide-treated cells (Fig. 4 D). Golgi refilling of GFP-
NRas was significantly more rapid than that of GFP-GPI (t
 
1/2
 
of 7 min) (Nichols et al., 2001), suggesting Ras recovery may
occur by an alterative mechanism. To test this possibility further,
we examined the effect of microtubule disruption by nocodazole,
which inhibits molecules internalized by clathrin-independent
pathways from reaching the Golgi complex (Choudhury et al.,
2002). In cells subjected to acute nocodazole treatment (Ward
et al., 2001), uptake of CTXB to the perinuclear region was in-
hibited. This treatment had no effect on trafficking of GFP-HRas
and GFP-NRas to the Golgi complex, however, suggesting this
event does not require vesicular transport (Fig. 5).
 
Dynamic depalmitoylation of HRas and 
NRas causes the proteins to 
redistribute to the ER and Golgi complex
 
Because Ras palmitoylation mutants are reversibly bound to
Golgi membranes (Fig. 1), we considered the possibility that
removal of palmitate on Ras could allow the protein to recycle
to the Golgi complex by a nonvesicular mechanism. To study
the contribution of depalmitoylation to Ras localization and
Figure 5. Recycling of GFP-HRas and GFP-NRas to
the Golgi complex occurs by a microtubule-independent
pathway. (A) Cells expressing GFP-NRas were sub-
jected to acute nocodazole treatment as described in
the Materials and methods before imaging. The
Golgi-associated pool of GFP-NRas was then selec-
tively photobleached (circle, t   0) and fluorescence
recovery was monitored over time. Bar, 10  m. (B)
Acute nocodazole treatment (NZ) inhibits delivery of
Cy3-CTXB to the perinuclear region after 20 min of in-
ternalization, a time point at which significant Cy3-
CTXB accumulation is observed in the perinuclear re-
gion in cells treated with vehicle alone (control). Bar,
10  m. (C and D) Kinetics of recovery of GFP-HRas
(C) and GFP-NRas (D) to the Golgi complex are not
significantly altered by acute nocodazole treatment.
Data are from a representative experiment at 37 C.
Bars   SE.
Figure 6. 2BP inhibits delivery of GFP-HRas and GFP-NRas, but not YFP-
GL-GPI, to the cell surface. COS-7 cells were treated with 2BP or vehicle
overnight immediately after transfection with (A) GFP-HRas, (B) GFP-NRas,
or (C) YFP-GL-GPI and imaged the following day. Bars, 10  m.JCB • VOLUME 170 • NUMBER 2 • 2005 266
trafficking, we examined the effect of an inhibitor of protein
palmitoylation, 2-bromo-palmitate (2BP) (Webb et al., 2000).
2BP inhibits trafficking of newly synthesized HRas to the cell
surface, causing it to accumulate on endomembranes (Michael-
son et al., 2001, 2002) (Fig. 6, A and B). We confirmed that
this is not due to a general defect in the secretory pathway be-
cause the cell surface expression of a GPI-anchored protein,
YFP-GL-GPI, is unaffected by 2BP treatment (Fig. 6 C).
We reasoned that by blocking palmitoylation after Ras
has been delivered to the cell surface, 2BP should cause the
accumulation of depalmitoylated protein by preventing its re-
palmitoylation. To test this, we allowed GFP-HRas or GFP-
NRas to be expressed overnight, treated with cycloheximide
for 4 h to inhibit new protein synthesis, then treated the cells
with 2BP for various times before imaging (Fig. 7 A). To
quantitate the effect of 2BP on the subcellular distribution of
Ras, we scored the fraction of cells exhibiting ER and/or nu-
clear envelope staining (Fig. 7 B). We also analyzed the ratio
of fluorescence in the Golgi region versus the whole cell after
2BP treatment (Fig. 7 C). After 30 min of 2BP treatment, the
fraction of NRas associated with the ER and Golgi complex
was significantly increased; by 2 h, the distribution of the
protein was similar to cells transfected in the presence of
2BP. GFP-HRas also redistributed to the ER and Golgi com-
plex in response to 2BP treatment in a time-dependent man-
ner, although the kinetics were slower than for GFP-NRas.
Photobleaching experiments confirmed that the fraction of
protein reversibly bound to the Golgi complex also increased
over time after 2BP treatment (unpublished data). We con-
clude from these studies that depalmitoylation of Ras allows
the protein to recycle from the cell surface to the ER and
Golgi complex.
Discussion
In this study we examined the role of palmitoylation in the
regulation of trafficking and subcellular localization of the
two major palmitoylated Ras isoforms, HRas and NRas. Us-
ing time-lapse microscopy in combination with fluorescence
photobleaching techniques, we show that GFP-tagged Ras
palmitoylation mutants undergo rapid and reversible exchange
between ER membranes, Golgi membranes, and the cytoplasm.
Figure 7. Time course of redistribution of GFP-HRas and GFP-NRas in response to 2BP treatment. (A) Cells were transfected with GFP-HRas or GFP-NRas,
allowed to express the protein overnight, and then treated with 2BP for the indicated times before imaging. Bars, 10  m. (B) Cells treated with 2BP were
scored for ER labeling as described in Materials and methods. Data show the mean   SE for four independent experiments. (C) Cells treated with 2BP
were scored for the fraction of Ras localized to the Golgi complex as described in the Materials and methods. Data are the mean   SE from three inde-
pendent experiments.ROLE OF PALMITOYLATION IN RAS TRAFFICKING • GOODWIN ET AL. 267
We also find that wild-type GFP-HRas and GFP-NRas are re-
cycled to the Golgi complex under steady-state conditions by a
mechanism involving a cycle of depalmitoylation and repalmi-
toylation of the protein. Our data indicate that Ras shifts be-
tween vesicular and nonvesicular modes of transport depending
on its palmitoylation state. These observations are summarized
in a working model for how palmitoylation modulates HRas
and NRas trafficking in Fig. 8. In this scenario, after farnesyla-
tion in the cytoplasm, newly synthesized Ras interacts with ER
membranes, where enzymes involved in the processing of the
Ras COOH terminus are localized (Dai et al., 1998; Schmidt et
al., 1998; Zhao et al., 2002). Depending on the location of the
putative Ras palmitoyltransferase, transport of Ras from the ER
to Golgi complex occurs by either a nonvesicular or vesicular
pathway. Once palmitoylated, HRas and NRas can be incorpo-
rated into Golgi-derived vesicles destined for the cell surface.
Depalmitoylation of Ras by a putative acyl protein thioesterase
or by nonenzymatic hydrolysis allows the protein to be released
from the cell surface and return by a nonvesicular transport
pathway to the Golgi complex and ER. Ras is then repalmitoy-
lated in the early secretory pathway and reenters a vesicular
transport pathway exiting the Golgi complex for the cell sur-
face. This model is in excellent agreement with the results of a
recent study examining the role of palmitoylation in the regula-
tion of the subcellular localization and signaling of palmitoylated
forms of Ras (Rocks et al., 2005).
Binding of nonpalmitoylated Ras to ER 
and Golgi membranes occurs 
independently of specific protein–protein 
interactions and is modulated by the 
nature of the prenyl group
Our in vivo measurements demonstrate that the CAAX motif is
sufficient to mediate efficient but rapidly reversible binding of
GFP to ER and Golgi membranes. These findings are in agree-
ment with classic biochemical fractionation experiments show-
ing that in the absence of a second signal, Ras exhibits reduced
membrane binding affinity (Hancock et al., 1990). However,
our data offer several new insights into the mechanisms under-
lying this reversible binding/partitioning. First, through quanti-
tative comparison of fluorescence recovery kinetics, we find
that Ras palmitoylation mutants and GFP-CVLS bind the Golgi
complex with nearly equal affinity (Fig. 1). Similarly, in the
ER, the behavior of GFP-CVLS and the palmitoylation mutants
was indistinguishable via photobleaching or FCS criteria (Figs.
2 and 3). Thus, in the absence of palmitoylation, Ras mem-
brane binding affinity is dominated by the COOH-terminal
membrane anchor. Although these data suggest that this bind-
ing occurs independently of specific protein–protein interac-
tions, the NH2-terminal domain of Ras did appear to modestly
enhance binding, as the halftimes of recovery for GFP-CVLS
were slightly faster than the palmitoylation mutants. A more
important contributor to binding is the hydrophobic nature of
Figure 8. Working model for how palmitoylation regulates HRas and NRas trafficking to and from the Golgi complex. (1) Before palmitoylation, newly
synthesized Ras can reversibly bind ER and Golgi membranes and traffic between them via a soluble cytosolic intermediate. (2) Palmitoylation via a puta-
tive palmitoyl acyl transferase (PAT) kinetically traps Ras onto membranes in the early secretory pathway, and (3) enables the protein to be packaged into
vesicles bound for the cell surface. Once reaching the cell surface, palmitoylated HRas and NRas can undergo endocytosis (not depicted). (4) Turnover of
palmitate generates a transiently depalmitoylated pool of protein that is returned to the Golgi complex and/or ER by nonvesicular transport, where it can
again interact with PAT and reenter the secretory pathway.JCB • VOLUME 170 • NUMBER 2 • 2005 268
the prenyl moiety, as GFP-CLLL, a substrate for geranylgera-
nylation, exhibited a twofold increase in binding compared
with the farnesylated proteins examined in this study (Figs. 2
and 3). Interestingly, this difference is much smaller than that
observed in in vitro studies, where geranylgeranylated peptides
exhibit a 45-fold higher effective partition coefficient than far-
nesylated peptides (Silvius and l’Heureux, 1994). Other factors
that could potentially modulate the membrane binding of
CAAX-containing proteins to ER and Golgi membranes in-
clude postprenylation processing of the CAAX motif (Michael-
son et al., 2005) and prenyl-binding proteins such as PRA1
(Figueroa et al., 2001). Binding to ER and Golgi membranes
may also depend on the specific amino acid composition of the
hypervariable domain, whether Ras is GTP or GDP bound, and
the cholesterol content of the membrane, factors recently
shown to regulate the strength of HRas binding to the plasma
membrane (Rotblat et al., 2004).
Because nonpalmitoylated Ras has access to the cytosol,
our findings raise the question of why it does not significantly
bind the plasma membrane (Choy et al., 1999; Apolloni et al.,
2000). One possibility is that the lipid composition of the ER
and Golgi membranes is preferable for insertion of prenyl
moieties. However, in vitro binding of prenylated peptides to
liposomes show little dependence on membrane composition
(Silvius and l’Heureux, 1994). Alternatively, membrane po-
tential and/or electrostatic interactions, which presumably are
responsible for the specific binding of KRas to the cell surface
(Choy et al., 1999; Apolloni et al., 2000), may play an inhibi-
tory role in preventing plasma membrane binding in the ab-
sence of a second plasma membrane binding signal. Finally, as
discussed in the previous paragraph, putative prenyl binding
proteins localized to the ER and Golgi complex could poten-
tially act as sites for transient binding interactions.
The palmitoylation state of Ras 
determines whether the protein 
undergoes vesicular or nonvesicular 
transport
Our data suggest that Ras can shift between vesicular and non-
vesicular transport by regulating its palmitoylation state in a
manner consistent with the “kinetic trap” model of palmitoyla-
tion (Shahinian and Silvius, 1995). This model proposes that
farnesylated (but nonpalmitoylated) peptides can efficiently but
reversibly bind membranes until they are palmitoylated, trapping
them on the membrane. Such kinetic trapping can readily explain
why Ras palmitoylation mutants are rapidly and reversibly
bound to membranes, whereas a substantial fraction of palmitoy-
lated HRas and NRas is stably bound to the Golgi complex.
As an extension of this model, we propose that the intra-
cellular sites at which Ras palmitoyl acyl transferase (PAT) en-
zymes reside define the entry points for Ras into vesicular
transport pathways. For example, if PAT activity is present in
the ER or intermediate compartment, newly synthesized Ras
would enter into vesicles early in the secretary pathway. Con-
versely, if the PAT activity is localized exclusively at the
plasma membrane, Ras could potentially traffic to the plasma
membrane completely independently of vesicular transport.
The latter possibility may explain why in adipocytes, delivery
of HRas to the cell surface occurs in the presence of BFA or af-
ter a 20  block (Watson et al., 2003). This nonclassical cell sur-
face transport pathway is an excellent candidate for regulation
via a cycle of palmitoylation and depalmitoylation (Watson et
al., 2003). A similar model could explain how peptides mimick-
ing the NRas COOH terminus reach to the plasma membrane
independent of the secretory pathway (Schroeder et al., 1997).
Our understanding of the role of palmitoylation in Ras
trafficking will be greatly enhanced by the identification of the
proteins responsible for this process. Although palmitoylation
can occur by nonenzymatic means, there is evidence that in
cells this is a regulated event (Dietrich and Ungermann, 2004;
Smotrys and Linder, 2004). Although the enzymes responsible
for palmitoyl transferase activity have long been sought (Kasi-
nathan et al., 1990; Gutierrez and Magee, 1991; Berthiaume
and Resh, 1995; Das et al., 1997), only recently have candidate
Ras PATs been identified. Studies in yeast first identified an
ER-localized protein complex, Erf2/Erf4, that stimulates pal-
mitoylation of Ras2 in vitro (Lobo et al., 2002). These proteins
contain a DHHC cysteine-rich domain that has been postulated
to be a signature of proteins involved in palmitoylation (Smot-
rys and Linder, 2004). Very recently, several candidate mam-
malian Ras palmitoyltransferases have been identified (Ducker
et al., 2004; Fukata et al., 2004; Huang et al., 2004). Given
these recent breakthroughs, it should be possible to begin to di-
rectly dissect the role of these proteins in Ras localization and
function in the near future.
It is important to note that the kinetic trapping model
does not exclude other potential roles for palmitoylation in the
regulation of Ras trafficking. For example, the yeast Ras ho-
mologue Ras2p is trafficked to the plasma membrane in the
absence of a functional secretory pathway in a process requir-
ing Erf2p, a putative ER-localized palmitoyltransferase, by an
as-yet-unidentified mechanism (Dong et al., 2003). It is possi-
ble that palmitoylation-dependent interactions allow Ras to
interact with chaperone proteins that traffic the protein by
vesicle-independent pathways. Alternatively, palmitoylation-
dependent targeting of Ras to raft-enriched or other types of
membrane microdomains may be important for allowing it either
to exit the Golgi complex (Magee and Marshall, 1999) or to be
internalized from the cell surface by either clathrin-dependent or
-independent endocytic pathways (Roy et al., 2002).
Regulation of the rate of 
depalmitoylation of NRas versus HRas
The potential for Ras to undergo multiple rounds of depalmi-
toylation and subsequent repalmitoylation were first suggested
by studies of NRas, which indicated that the half-life of palmi-
tate is shorter than the life span of the protein (Magee et al.,
1987). One enzyme that has been demonstrated to remove
palmitate from HRas in vitro is acyl-thioesterase 1 (Smotrys
and Linder, 2004). However, much remains to be learned about
how this event is regulated. Although it is tempting to speculate
that the primary pool of Ras undergoing depalmitoylation is
localized to the cell surface, it is unclear whether specific sub-
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Interestingly, we found that the rate of palmitate turn-
over differs for HRas and NRas. First, a larger fraction of
wild-type NRas than HRas was reversibly bound to the Golgi
complex (Fig. 4). This implies that a larger fraction of NRas
than HRas is present in a depalmitoylated state under steady-
state conditions. In addition, after 2BP treatment NRas redis-
tributed to the ER and Golgi more rapidly than HRas (Fig. 6),
suggesting that NRas undergoes a more rapid rate of depalmi-
toylation. These observations are consistent with reports that
the half-life of palmitate on HRas, ranging from 90 min to 2.4
h (Lu and Hofmann, 1995; Baker et al., 2003), is relatively
long compared with that of NRas (20 min) (Magee et al.,
1987). Because HRas contains two palmitoylation sites com-
pared with NRas’s one, it is likely that the difference in overall
half-lives reflects a higher probability that at least one palmi-
tate will be present on HRas. Indeed, the half-life of palmitate
on overexpressed HRas was previously shown to be reduced
from  90 min to 15 min upon mutation of one of the palmi-
toylation sites, with slower turnover correlating with stronger
membrane binding (HRas Ser181) (Lu and Hofmann, 1995).
This same study showed little evidence for specific recogni-
tion of palmitoylated proteins, thus suggesting that access to a
depalmitoylating enzyme determined the palmitate turnover
rate. Our finding that depalmitoylation plays a role in deter-
mining the subcellular distribution and trafficking of HRas
and NRas highlights the need for further characterization of
the regulation of these events.
Nature of the soluble pool of Ras
The presence of a soluble pool of Ras has been noted by sev-
eral groups, with the fraction of soluble protein ranging from
10–20% to upwards of 40–50% (Magee et al., 1987; Hancock
et al., 1990; Lu and Hofmann, 1995; Choy et al., 1999; Webb et
al., 2000; Baker et al., 2003). Our data suggest that this soluble
pool corresponds to transiently depalmitoylated Ras, in agree-
ment with a previous study showing that soluble NRas is farne-
sylated but not palmitoylated (Magee et al., 1987). How Ras is
solubilized in the presence of a farnesyl moiety is not yet
known. Delivery of geranylgeranylated Rab proteins to mem-
branes is mediated by Rab escort protein (REP) or a Rab GDP
dissociation inhibitor (GDI) (for review see Seabra and Was-
meier, 2004). The prenylated Rab acceptor protein (PRA1) and
phosphodiesterase-  are two candidate Ras escort proteins
(Figueroa et al., 2001; Hanzal-Bayer et al., 2002; Nancy et al.,
2002). However, it should be noted that in vitro peptide bind-
ing experiments show that farnesylated proteins have an intrin-
sically weak affinity for membranes, and thus may not require
a specialized mechanism to allow them to become solubilized
(Silvius and l’Heureux, 1994). Yet another possibility, sug-
gested by biochemical studies in progress, is that soluble farne-
sylated Ras exists as a dimer (unpublished data). Our FCS stud-
ies show that soluble Ras has a diffusional mobility similar to
cytoplasmic GFP (Fig. 3, Table I). Given the weak dependence
of diffusion on protein size, these data are consistent with the
possibility that soluble Ras exists either as a monomer or in
small complexes with itself or other proteins. More work will
be required to distinguish between these possibilities.
Implications for Ras signaling
We envision several mechanisms by which the regulation of the
palmitoylation state of Ras could control the intracellular loca-
tion and time course of Ras signaling. First, the loss of palmitate
on Ras may allow for the regulated release of the protein from
the cell surface. Such an event could even be regulated by Ras
activation itself, as the depalmitoylation of GTP-bound HRas is
accelerated compared with the GDP-bound form (palmitate half-
life of 10 min vs. 2.4 h, respectively) (Baker et al., 2003). Given
that depalmitoylated Ras can still efficiently bind intracellular
membranes, such an event may not have a large effect on the
subcellular distribution of Ras as assessed by biochemical crite-
ria. This could explain why 2BP treatment causes only a 7–20%
increase in the soluble pool of HRas (Webb et al., 2000). After
depalmitoylation, activated Ras could itself act as a diffusible
signaling intermediate, allowing the protein to rapidly redistrib-
ute to other intracellular compartments. Evidence supporting
this model was very recently reported (Peyker et al., 2005;
Rocks et al., 2005). The reversible binding of depalmitoylated
Ras may also explain the rapid ( 2 min after stimulation) re-
cruitment of GFP-RBD to ER membranes in cells overexpress-
ing HRas palmitoylation mutants (Chiu et al., 2002). This also
implies that reversible membrane binding of Ras is sufficient to
enable efficient signaling. Finally, a cycle of depalmitoylation
and repalmitoylation may regulate intracellular Ras signaling by
maintaining a steady-state pool of Ras on the Golgi complex
(Chiu et al., 2002; Bivona et al., 2003; Caloca et al., 2003; Mitin
et al., 2004; Perez de Castro et al., 2004; Rocks et al., 2005).
This may also contribute to the specific outcomes of HRas
signaling in response to altered membrane-targeting signals
(Booden et al., 1999, 2000; Coats et al., 1999). Disruption of Ras
recycling to the Golgi complex may thus offer a potential mech-
anism to interfere with oncogenic Ras activity.
Materials and methods
DNA constructs, cell transfections, and fluorescent probes
COS-7 cells were maintained in DME supplemented with 10% fetal calf
serum at 5% CO2 and 37 C. Cells were transfected using FuGENE 6
(Roche Diagnostics) according manufacturer’s protocol and imaged 1 and
2 d after transfection. cDNA for GFP-Ras chimeras (EGFP-CVLS, EGFP-
CLLL, EGFP-HRas C181S, C184S, EGFP-NRas C181S, EGFP-HRas, and
EGFP-NRas) and GFP-GPI were as previously described (Choy et al.,
1999; Nichols et al., 2001). Note that no linkers were used in the con-
struction of EGFP-CLLL and EGFP-CVSL. For simplicity, EGFP is referred to
as GFP in the text. Control experiments confirmed that the CAAX motif of
overexpressed GFP-Ras is quantitatively processed, and that in the ab-
sence of farnesylation the protein is not associated with any intracellular
membranes (Fig. S1, available at http://www.jcb.org/cgi/content/full/
jcb.200502063/DC1). CTXB (Sigma-Aldrich) was fluorescently labeled
with Cy3 according to the manufacturer’s instructions (GE Healthcare).
Cells were labeled with 1  g/ml Cy3-CTXB for 15 min on ice and washed
several times before imaging or drug treatments.
Nocodazole and cycloheximide treatments
To disrupt microtubules, cells were preincubated for 5 min on ice in DME
containing 10% fetal calf serum and 50 mM Hepes. The cells were then
treated with 5  g/ml nocodazole (Sigma-Aldrich) for 15 min on ice,
warmed for 5 min to 37 C, and imaged in the continued presence of no-
codazole at 37 C. Control experiments were performed using vehicle
alone (DMSO). To inhibit new protein synthesis, cells were treated with
200  g/ml cycloheximide (Sigma-Aldrich) in DME, 10% fetal calf serum,
and 50 mM Hepes for 4 h at 37 C. The cells were then imaged at 37 C in
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Fluorescence microscopy and photobleaching measurements
Cells were imaged with an inverted laser scanning confocal microscope
(model 510; Carl Zeiss MicroImaging, Inc.) equipped with the Confocor2
for FCS (Carl Zeiss MicroImaging, Inc.). Where indicated, an Air Stream
Stage Incubator (Nevtek) was used for imaging at 37 C. GFP was excited
with an argon laser with excitation at 488 nm and emission was detected
with a GFP long-pass (LP) 505 or 530 or band-pass (BP) 505–530 filter.
A Plan-Neofluar 40 /1.3 oil immersion lens was used for imaging all
samples. Cells were maintained in phenol-red free DME containing 10%
fetal calf serum and 50 mM Hepes for live-cell imaging experiments.
Confocal FRAP measurements were performed using a previously
described protocol (Kenworthy et al., 2004). In brief, a strip 4  m wide
was photobleached using high laser intensity and fluorescence recovery
monitored at low intensity. Diffusion coefficients were calculated from
whole-cell recoveries using a program that simulates diffusion (Siggia et
al., 2000). Mf was calculated as described previously (Ellenberg et al.,
1997). Statistical differences were evaluated using the t test.
In experiments measuring kinetics of Golgi refilling, an area con-
taining the entire Golgi was bleached (Nichols et al., 2001). Halftimes of
recovery were calculated as described in Feder et al. (1996), and the final
percentage of recovered fluorescence was calculated as for Mf after cor-
recting for the loss of fluorescence due to the photobleaching event.
Control experiments on fixed cells confirmed that the loss of fluorescence
was confined to the bleached region.
All quantitative image analysis was performed using unprocessed
images. For presentation purposes, image contrast was adjusted using
Adobe Photoshop.
Quantitation of Ras localization after 2BP treatment
Cells were treated with 25  M 2BP (Sigma-Aldrich) or vehicle (DMSO) at
37 C, either immediately after transfection or 18 h after transfection for the
indicated times (30 min, 2 h, or 5 h). After treatment, cells were imaged live
with the confocal pinhole fully open for quantitation or set at 1–2 Airy units
for presentation purposes. The subcellular distribution of Ras in  20 cells/
treatment was quantitated in two ways. (1) Localization of Ras in the ER/
nuclear envelope versus plasma membrane. Cells were scored for the rela-
tive amounts of ER/nuclear envelope labeling ranging from ER labeling but
no apparent plasma membrane stain (    ) to no apparent ER or nuclear
envelope label (    ). These scores were converted to a numeric value
as follows:      (1 pt),    /  (0.75 pt),   /   (0.5 pt),  /   
(0.25 pt), or      (0 pt). The total numeric score for all cells at a given
time point was calculated for each experiment. (2) Fraction of Ras localized
to the Golgi complex. Images were converted to tiff format, and the average
fluorescence in the Golgi region versus in the entire cell was calculated
using NIH Image. After background subtraction, the ratio of fluorescent
material in the Golgi region versus the entire cell was calculated.
Fluorescence correlation spectroscopy
FCS measures time-dependent fluorescence fluctuations in a diffraction-lim-
ited (0.1 femtoliter) volume defined using confocal microscope optics with
a sensitive avalanche photodiode detector. Intensity fluctuations corre-
sponding to the movements of individual molecules in and out of the confo-
cal volume are recorded over time. Fluorescence fluctuations reflect the av-
erage residence time of the fluorescent species in the confocal volume,
which in turn are a function of its characteristic diffusional mobility. The
diffusion of fluorescently tagged proteins through the sampling volume oc-
curs with a characteristic  D. This is related to the diffusion coefficient D by
 D   ( 0
2)/(4D), where  0 is the radius of the laser beam. Thus, a longer
 D corresponds to a slower D. The intensity fluctuations are characterized
by their average value  I  and their fluctuations  I(t)   I(t)    I  and
can be analyzed using an autocorrelation function G( ). The normalized
autocorrelation function is given by G( )   1     I(t) *  I(t    )  *
 I 
 2, where I(t) is the time-dependent fluorescence intensity,   is a short
time interval after any arbitrary time t, and  I  is the mean value of fluo-
rescence intensity.
FCS experiments were performed on a microscope (LSM 510; Carl
Zeiss MicroImaging, Inc.) outfitted with ConfoCor2 (Carl Zeiss MicroImag-
ing, Inc.), combining both FCS and confocal laser scanning capabilities.
A C-Apochromat 40  1.2 NA water objective was used in conjunction
with a dichroic filter and 520-nm long-pass filter to focus and separate ex-
citing and emitting radiation. GFP-tagged constructs were excited at
488 nm with a 40-mW argon laser. Aqueous rhodamine 6G solutions
were used to calculate the confocal volume radius  0   1.44   10
 7 m,
resulting in a confocal volume element of 0.1 fl.
Cells were imaged in LSM mode and, after selection of an appropri-
ate cell, whole cells were repeatedly bleached to reduce the fluorescence
to allow for FCS measurements. A line scan in the axial direction was per-
formed to set the volume element at an appropriate position in the cell.
FCS measurements were made for 10 s each and repeated 10 times per
cell. The autocorrelation curves were fit using software provided by the
manufacturer. The autocorrelation function G( ) for a two-component
model is described by the following equation: G( )   1   (1/N) [(1   Y)
(1    / D1)
 1 (1    /S
2  D1)
 1/2   Y (1    / D2)
 1 (1    /S
2  D2)
 1/2].
Here, N is the number of fluorescent particles in the confocal vol-
ume; S is the structure parameter (defined by the dimensions of the confo-
cal volume);  D1 and  D2 are the average residence times of the first and
second component, respectively; and Y and 1   Y are the fraction of par-
ticles in the confocal volume with diffusion time  D2 and  D1, respectively.
Data were fit assuming a constant structure parameter of 5.0. Diffusion co-
efficients were calculated from the fitted values of  D and the known confo-
cal radius  0 as described above. Data were obtained from 10–20 cells
from two independent experiments.
Online supplemental material
The online supplemental material describes control experiments performed
to test whether overexpressed GFP-Ras fusion proteins are quantitatively
farnesylated, and is available at http://www.jcb.org/cgi/content/full/
jcb.200502063/DC1.
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